Literature DB >> 2233246

Tolerance to self-antigens in transgenic mice.

T E Adams1.   

Abstract

Transgenic mice represent a versatile experimental approach for understanding the pathways by which the immune system regulates responsiveness to self-antigens, thereby establishing self-tolerance. The introduction of immunoglobulin and T cell receptor genes with specificity for self-antigens into the germline of mice has enabled the fate of self-reactive lymphocyte precursors to be followed in vivo. The influence of both developmentally regulated, and tissue-specific gene expression on tolerance to self-antigens has been addressed using transgenic mice expressing novel self-antigens under the transcriptional control of heterologous gene promoters. The generation of transgenic mice expressing structurally altered forms of self-antigens has allowed the role of antigen-processing in the induction of tolerance to be examined. Significantly, while these studies have confirmed the classically derived principles of immunological self-tolerance, they also point to the existence of pathways, as yet undefined, by which tolerance to self-antigens may be implemented and maintained.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2233246

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN: 0735-1313


  4 in total

1.  The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model.

Authors:  J L Ottesen; P Nilsson; J Jami; D Weilguny; M Dührkop; D Bucchini; S Havelund; J M Fogh
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

2.  Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies.

Authors:  Weina Li; Yonggang Ran; Meng Li; Kuo Zhang; Xin Qin; Xiaochang Xue; Cun Zhang; Qiang Hao; Wei Zhang; Yingqi Zhang
Journal:  BMC Biotechnol       Date:  2013-09-27       Impact factor: 2.563

3.  A transgenic model of autoimmune hemolytic anemia.

Authors:  M Okamoto; M Murakami; A Shimizu; S Ozaki; T Tsubata; S Kumagai; T Honjo
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

4.  Transgenic expression of non-structural genes of Theiler's virus suppresses initial viral replication and pathogenesis of demyelination.

Authors:  Hyun Seok Kang; Jinjong Myoung; Eui Young So; Young Yil Bahk; Byung S Kim
Journal:  J Neuroinflammation       Date:  2016-06-01       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.